DJIA 15,660.18 -254.56 -1.60%
NASDAQ 4,266.84 -16.76 -0.39%
S&P 500 1,829.08 -22.78 -1.23%
market minute promo

Novartis (NYSE: NVS)

72.20 -0.79 (-1.08%)

REAL-TIME: Last trade at

company name or ticker

Recent Quotes

NVS $72.20 -1.08%
Company Photos
(Click to zoom)
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $72.31
Previous Close $72.99
Daily Range $71.55 - $72.59
52-Week Range $71.55 - $106.84
Market Cap $173.0B
P/E Ratio 19.73
Dividend (Yield) $2.67 (3.2%)
Ex-Dividend Date
Dividend Pay Date
Volume 2,357,210
Average Daily Volume 2,496,377
Current FY EPS $5.19




Drug Makers

Novartis (NVS) Description

Operates in the business of patent-protected and generic pharmaceuticals as well as consumer health products. Website:

News & Commentary Rss Feed

Will 2016 Be Novartis' Worst Year Yet?

WIth its top seller facing increased generic competition, this could be a very bad year, indeed.

These O'Shares ETFs Focus On Quality European Dividends

AveXis IPO: We Like This Goldman-Led Deal

Why Radius Health Inc. Dropped 45% in January

Good news from the clinical-stage osteoporosis specialist couldn't overcome January's biotech beat down.

Pre-Market Most Active for Feb 8, 2016 : CBX, NVS, TVIX, AZN, NOK, MT, BCRX, QQQ, FB, XIV, BAC, APO

Pre-Market Most Active for Feb 8, 2016 : CBX, NVS, TVIX, AZN, NOK, MT, BCRX, QQQ, FB, XIV, BAC, APOL

3 Potential Blockbusters Moving the Needle for Big Pharma in 2016

These pharmas have some recently approved drugs that could singlehandedly boost total sales this year.

Biogen Inc. Takes Aim at Johnson & Johnson

Biogen's Samsung Bioepis has Remicade in its crosshairs.

Why Ophthotech Corporation Shares Tumbled 31% in January

The launch of trials in dry age-related macular degeneration failed to spark shares last month.

Valeant's Share Price Continues to Decline

CAH Named Top 25 SAFE Dividend Stock Increasing Payments For Decades

See More NVS News...

NVS's Top Competitors

NVS $72.20 (-1.08%)
Current stock: NVS
JNJ $101.70 (-0.03%)
Current stock: JNJ
MRK $48.85 (-1.37%)
Current stock: MRK
GSK $39.15 (0.05%)
Current stock: GSK